Based on lineage and activation markers, transcription factor expression, and functional response (cytokine secretion and granzyme B expression), we were able to define 20 different clusters of immune cells subsets in the tumor, which could be categorized into eight separate CD4 and CD8 T-cell populations. The gene discussed is GZMB; the disease is neoplasm.